Development of mobile-based virtual reality - biofeedback and biomarker measuring system to reduce depressive mood and anxiety in general population

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004434

Enrollment

120

Registered

2019-11-14

Start date

2019-12-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : Through the execution of the screening test, we target 80 people who feel depressed and insecure from PHQ-9 and PDS surveys among normal groups without mental, neurological or physical diseas

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Criteria for selection of depression and anxiety groups • Not being treated for depression, anxiety disorder within 6 months • PHQ-9 (Patient Health Questionnaire–9) = 10 or Panic Disorder Severity Scale (PDSS) = 9 Normal control selection criteria • Does not satisfy the diagnosis of major depression or anxiety disorder on the basis of DSM-5 • PHQ-9 < 10 and PDSS < 9?• Have to voluntarily state his/her participation in the study and sign a consent form?• Clear from clinically unstable history of internal or surgical disease and no abnormalities in physical and neurological examinations

Exclusion criteria

Exclusion criteria: Patients with one or more of the following conditions: • Patients with past or present symptoms of psychotic disorders (e.g. schizophrenia, delusional disorder, etc.) • Patients with bipolar disorder • Have degenerative neurological conditions such as Parkinson's disease, Huntington's chorea, or dementia • Suspected mental retardation • Have other medical conditions that require treatment (e.g. Cancer) • Have a past or present history of convulsive disease (e.g. epilepsy) • Patients suspected of drug addiction or dependence, including alcohol, within the past 6 months • Suspected clinically meaningful personality disorder • Suspected brain damage

Design outcomes

Primary

Measure	Time frame
K-Montgomery °Asberg Depression Rating Scale;State-Trait Anxiety Inventory-X1;visual analog scale(VAS);Simulator Sickness Questionnaire;Presence Questionnaires;Satisfaction Scale	—

Secondary

Measure	Time frame
Adverse Event	—

Countries

Korea, Republic of

Contacts

Public ContactHongjin Jeon

Sungkyunkwan University

jhj001001@gmail.com+82-2-3410-3586

Outcome results